Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique

J Neural Transm. 1987;70(3-4):241-50. doi: 10.1007/BF01253601.

Abstract

The acute effect of 1-methyl-4-phenylpyridinium ion (MPP+), a neurotoxin derived from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), was examined by the in vivo micro-dialysis technique. A dialysis cannula was implanted into rat striatum, and the changes in the concentrations of dopamine (DA), 3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA) in the perfusate every 20 min after administration of MPP+ were determined by high-performance liquid chromatography with electrochemical detection (HPLC-ED). After MPP+ administration the levels of DOPAC, HVA and 5-HIAA were markedly decreased. On the contrary the level of DA was markedly increased and reached a maximum 40 min after beginning of the MPP+ administration. By postmortem analysis of the striatal tissue MPP+ was proved to cause the inhibition of monoamine oxidase (MAO), especially MAO-B. These results suggest that the acute biochemical changes induced by MPP+ in vivo were MAO inhibition and release of DA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenylpyridinium
  • Animals
  • Chromatography, High Pressure Liquid
  • Corpus Striatum / drug effects
  • Corpus Striatum / enzymology
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • Male
  • Monoamine Oxidase / metabolism
  • Neurotoxins / analysis
  • Neurotoxins / pharmacology*
  • Pyridinium Compounds / analysis
  • Pyridinium Compounds / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Serotonin / metabolism*

Substances

  • Neurotoxins
  • Pyridinium Compounds
  • Serotonin
  • Monoamine Oxidase
  • 1-Methyl-4-phenylpyridinium
  • Dopamine